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ABSTRACT 
 
Investigation of Immunoglobulin Heavy Chain Isotypes in an Ancestral Mucosal 
Immune Model. (August 2011) 
Christina C.  Du, B.A.; B.S., University of California, Irvine; D.V.M., Ross University 
Chair of Advisory Committee: Dr. Michael F. Criscitiello 
 
 The importance of gut associated lymphoid tissues has been extensively reported 
in higher vertebrates, but less is known in lower vertebrates. In mammals 
immunoglobulin (Ig)A is the primary Ig  of mucosal immunity.  But no IgA has been 
identified in cold-blooded animals. In higher vertebrates, antigen must stimulate the 
lymphoid tissues in the intestines to elicit an IgA response, and cytokines from CD4 
positive helper T cells are required for B cell switch. It is not known if this is the case in 
lower vertebrates, or if T cell help evolved before or after class switch recombination 
between functional antibody isotypes. My study will fill in these gaps in our knowledge 
by comparing oral antigen inoculation relative to intraperitoneal antigen inoculation in 
frogs (Xenopus sp.). Oral immunization is a novel approach to eliciting immune 
responses in Xenopus.  I propose that IgX will increase with oral inoculation compared 
to intraperitoneal injection.  This would be the first demonstration of class switch upon 
oral immunization to a mucosal isotype in the first vertebrates that employs higher 
vertebrate Ig heavy chain switch mechanism, which would shed light on the most 
fundamental aspects of our humoral adaptive immune system.  
 iv 
 Using a total Ig ELISA protocol, measuring total relative levels of IgM, there 
was no difference between the first three groups of orally immunized frogs compared to 
intraperitoneally immunized frogs.  However, a response to serum IgX was seen in the 
first group.  On the other hand, the refined Ag-specific ELISA protocol did present a 
significant increase in serum IgM response in frogs immunized systemically over orally 
immunized animals, but not an overall IgX response.   
 Phylogenetic analysis suggests that, contrary to initial reports, IgA evolved from 
IgX. With consideration of entire constant region and individual constant domain 
analyses as well as synteny and function, we suggest new hypotheses of vertebrate 
antibody evolution to be tested as immunogenetic coverage of more species continues to 
expand.  
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1. INTRODUCTION AND 
LITERATURE REVIEW 
 
Xenopus laevis, from an evolutionary standpoint, is the choice model for many 
adaptive immune system studies.  Aside from the fact that they can easily be 
manipulated during larval stages and have limited maternal and environmental 
influences during early development, Xenopus are the most primitive major model 
species that share a fundamentally similar immune system to humans (Du Pasquier et al. 
1989).   All vertebrates’ first line of defense is the innate immune system, which is ready 
at birth.  It involves barriers, anti-microbials, phagocytosis, inflammation, and 
complement.  The innate system can be activated by foreign molecules with pathogen-
associated molecular patterns (PAMPs). These are recognized by germline-encoded 
pattern recognition receptors (PRRs) on specific cells, which initiate a cascade of events, 
the end result being elimination of the pathogen.  It is fast to respond and non-specific 
for any individual pathogen.  On the other hand, the adaptive immune system of 
vertebrates is slow, with high molecular specificity and a memory component.  It is 
executed by lymphocytes and requires induction by antigen presenting cells. The 
adaptive immune system provides the ability to recognize and mount responses to 
pathogens.  This mechanism allows a small number of genes controlled by  
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somatic recombination activating gene (RAG) dependent rearrangement to generate a 
vast repertoire of different antigen receptors.  
An important aspect of adaptive immunity is that an individual can be 
immunized against a specific antigen in a process called vaccination.  It is generally 
long-term and protects when the same antigen is encountered a second time.  The 
immune response will be different than the first time it was encountered.  It will be faster 
because specific lymphocytes have already undergone clonal expansion and affinity 
maturation. When B cells and T cells are activated, some become memory cells. These 
memory cells form an expanded database of B and T lymphocytes. This process occurs 
when a random, diverse primary repertoire of lymphocyte specificities is created in the 
thymus and bone marrow. After removal of cells that recognize self, the remaining 
mature, naive cells populate the secondary lymphoid tissues. On binding specific 
antigen, the lymphocyte is activated to clonally expand and produce progeny specific to 
that antigen. Upon interaction with a previously encountered antigen, the specific 
memory cells are selected and activated. In this manner, the second and subsequent 
exposures to an antigen produce a stronger and faster immune response. This is 
"adaptive" because the body's immune system prepares itself for future challenges.  
The adaptive humoral immune response is responsible for the production of 
antibodies that bathe the extracellular spaces and neutralize and flag extracellular 
pathogens and toxins for destruction.  B cells, necessary for the production of antibodies, 
usually require helper T cells to help differentiate into antibody-secreting plasma cells. 
Antibodies can be either secreted or act as a surface receptor. Antibodies have three 
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basic functions: neutralization, opsonization and complement activation; to bind to 
molecules that elicit an immune response, to neutralize complete virus or bacterial cells 
and to signal to other cells to destroy the foreign pathogen. Antibodies have a similar 
basic structure comprising variable regions and a constant region and consist of di-
sulfide linked light and heavy chains, made of constant and variable immunoglobulin 
superfamily domains. The antigen-binding region varies extensively between antibody 
molecules.  The total repertoire of antibodies made by an individual allows any foreign 
structure to be recognized.  The constant region does not carry this variation and is 
greatly conserved across evolution.  The constant regions are important for 1) binding Fc 
receptors 2) binding complement and 3) delivering antibodies to specific locations such 
as colostrum, gut lumen or across the placenta. RAG-mediated V(D)J rearrangement 
increases diversity of the variable region, while class switch recombination (also known 
as isotype switching) maintains the variable region and switches the constant regions.  
Five immunoglobulin isotypes have been identified in humans: IgM, IgD, IgG, 
IgE and IgA.  The first antigen receptors expressed by B cells are IgM and IgD and can 
be expressed without class switch recombination. IgM largely functions in complement 
activation.  Function for IgD was generally unknown until recent studies showed that it 
aides activation of basophils and eosinophils (Chen et al. 2009).  IgG is the most 
abundant isotype in serum and (like IgM) is able to cross the placenta.  IgE functions in 
parasitic and allergic response, and IgA, by far the most abundant isotype in the body, is 
the major mucosal immunoglobulin.  Aside from functional differences, there are 
structural differences between the isotypes in their number of constant domains, 
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tendency to polymerize, and presence or absence of a hinge region.  The 
immunoglobulin isotypes are encoded at the heavy chain locus by a cluster of 
immunoglobulin heavy-chain C-region genes.  These heavy chain clusters are split into 
exons that correspond to an individual immunoglobulin domain.  In mammals, the same 
assembled variable region may be expressed in IgG, IgA or IgE antibodies, after class 
switch from IgM. Switch of the constant region occurs through non-homologous DNA 
recombination and is guided by switch regions upstream of each gene. This process is 
mediated by several enzymes including AID (the activation induced cytidine 
deaminase), and create nicks in the DNA. The two switch regions are brought together 
and the coding regions and DNA between the regions are deleted.  For example, the B 
cell with a heavy chain VDJ rearrangement that recognizes a helminth would now be 
able to make that specific V domain on IgE instead of IgM. 
Cartilaginous fish are the oldest animals that have an adaptive immune system 
based upon rearranging immunoglobulin superfamily antigen receptors. They have the 
same genes encoding the RAG recombinase that lead to immunoglobulin and T cell 
receptor gene rearrangement and a polygenic, polymorphic major histocompatibility 
complex.  Amphibians are the oldest vertebrates that share with mammals the capability 
of class switch recombination (Du Pasquier et al. 2000).  Fellah et al., concluded that 
amphibians may have been the species in which diversification of Ig occurred which 
lead to various Ig isotypes in higher species (Fellah et al. 1993).  Therefore, Xenopus 
laevis is the best choice for our research model to study the evolution of mucosal 
immune isotypes. 
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The major barrier breached by most pathogens is the mucosal surface, which 
comprises an enormous area to be protected.  This includes the gastrointestinal tract, the 
respiratory tract, the urogenital tract, salivary glands, lactating glands and the 
conjunctiva of the eye.  In mammals, secretory IgA is the predominate immunoglobulin 
of the mucosal surfaces and recognition of antigen in mucosal immune tissues causes B 
cell switch to this isotype.  However, IgA has not been identified in cold-blooded 
vertebrates, and little has been studied of the evolution of our secretory mucosal 
immunoglobulin despite its importance in host defense.  
In humans, the thymus is required for T cell maturation and the spleen is the 
main peripheral organ where T and B cells migrate to sample antigen and become 
activated (Hsu 1998).  At mucosal surfaces, the resident lymphoid tissues comprise the 
mucosal associated lymphoid tisssues (MALT).  MALT is further broken down into 
bronchial-associated lymphoid tissue (BALT) and gut-associated lymphoid tissue 
(GALT), as well as others.  GALT include the tonsils, adenoids, appendix and Peyer’s 
patches in the distal ileum.  Other animals have similarly organized lymphoid organs in 
the intestines, such as those observed in the rabbit appendix (Becker and Knight 1990), 
the Peyer’s patch in sheep (Reynaud et al. 1995) and the bursa of Fabricius in avian 
species (Cooper et al. 1966).  In humans, the effector site of intestinal immune responses 
is the lamina propria, consisting of a heterogenous group of lymphoid and myeloid cells 
concentrated in germinal centers.  These cells, including lymphocytes, macrophages, 
dendritic cells, neutrophils and mast cells, are responsible for production of a vast array 
of cytokines that aid in IgM to IgA isotype switching, nurture IgA B cell differentiation, 
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and secrete factors that aid in the transport of IgA from the lamina propria to the lumen 
(Malik et al. 2010).  In the gut-associated lymphoid organs, naïve B cells must be 
stimulated by activated T cells.  This in turn promotes B cell proliferation and 
maturation and leads to clonal expansion of memory B cells and antibody producing 
plasma cells.  Xenopus laevis, the oldest vertebrate that shares the mammalian capability 
of immunoglobulin class switch recombination, apparently does this without germinal 
center formation required for B cell maturation (Du Pasquier et al. 2000).  Xenopus, 
similarly to humans, do have thymus as a primary T lymphoid organ and a secondary 
peripheral organ in the spleen, but unlike mammals, they lack lymph nodes, germinal 
centers and Peyer’s patches.   
Other heavy chain isotypes have been described, besides our five, from other 
vertebrate groups.  IgM has been well studied across species and is widely expressed 
throughout most immune tissues. IgM is conserved across vertebrates from shark to 
man.  The identification of IgD in Xenopus (Ohta and Flajnik 2006), IgW in lungfish 
(Ota et al. 2003) and IgW in shark (Harding et al. 1990) has also linked mammalian IgD 
to an ancient origin in cartilaginous fish.  IgY is identified in amphibians, reptiles and 
birds.  In fact, the expression and function of IgY in amphibians has been shown to be 
similar to mammalian IgG and IgE, and phylogenetically has been shown to be the 
ancestor of these mammalian isotypes.  In fact, the expression and function of IgY in 
Xenopus is similar to mammalian IgG and IgE and shows similarity to rabbit and ox IgG 
extracellular domains (Mussmann et al. 1996).  The constant domains of IgF are very 
similar to IgY, indicating that they arose from a duplication event (Zhao et al. 2006).  
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IgX is similar to IgM, with four constant domains and forming polymers, but is not 
associated with the secretory J chain, yet is expressed by plasma cells found in the 
lamina propria of the gut epithelium (Mussmann et al. 1996).  As in the case of IgA, 
polymerization with J chain is required for transport through epithelia.  Expression of 
IgM and IgX are thymus independent and IgY is thymus dependent (Fellah et al. 1993) 
as determined by studies using intraperitoneal immunization. Recent literature has 
identified IgZ/IgT in teleost fish (Danilova et al. 2005) as a mucosal-associated 
lymphoid tissue immunoglobulin and it was suggested that this may be the last distinct 
isotype to be discovered (Flajnik 2005).  Although, no J chain has been associated, IgT 
has been found to be a polymer in gut mucosa and a secretory component has been 
identified. IgT clearly shows homology to IgM, but no relationship to other isotypes has 
been found, suggesting that it arose after bony fish diverged from other vertebrates.  
Thus we have a very good idea of where four of the five antibody classes of placental 
mammals came from. IgM and IgD are ancient from the dawn of the system, IgG and 
IgE came from amphibian IgY.  The natural history of IgA has not been as clear. An 
article by Mussmann in 1996 reported up to 60% of the B cells identified in the gut of 
the frog Xenopus laevis were IgX secretors, however, these were hardly identifiable in 
liver, spleen (Mussmann et al. 1996) or serum (Hsu 1998).  Mussman also reported that 
systemic immunization in Xenopus elicited an IgM and IgY response, but not an IgX 
response.  This mucosal localization of frog IgX, coupled with early reports of sequence 
similarity between IgM and IgX, suggested that IgX might be the functional analog, but 
not the ortholog of IgA  (Hsu et al. 1985).  
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My hypothesis is that frog IgX, a proposed functional analog of our IgA isotype, 
will be specifically produced against oral immunization and is in fact an ortholog of our 
IgA.  I believe it shares a common ancestor with our IgA in early tetrapod.  I propose 
that IgX will increase with oral inoculation compared to intraperitoneal injection and 
that IgM will be increased in systemically challenged animals compared to orally 
challenged animals.  Oral immunization is a novel approach to eliciting immune 
response in Xenopus and this methodology will have to be developed.  This would be the 
first demonstration of class switch upon oral immunization to a mucosal isotype in the 
first vertebrates that employ our Ig heavy chain switch mechanism.  We do not know if 
T cell help evolved before or after class switch recombination.  Results would shed light 
on the most fundamental aspects of our humoral adaptive immune system.   My study 
will fill in these significant gaps in our knowledge by inoculating frogs orally and 
comparing this route to intraperitoneally immunized frogs.  This work will be 
complemented by phylogenetic analysis of IgX and IgA in light of recent 
immunoglobulin findings in diverse tetrapods. 
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2. MATERIALS AND METHODS 
 
2.1. Development of Frog Experimental Techniques 
 Xenopus laevis were initially purchased from Xenopus Express (Brooksville, 
Florida).  Animals were housed in two XenoPlus (Tecniplast) recirculating systems. 
Tanks are constructed of polycarbonate with two water delivery pipes nested within each 
other.  This system allows reduction of cleaning operations and minimizes overflow if 
debris clogs the outer pipe.  A sleeve with smaller holes fits over the outer pipe for 
tadpoles.  The system is equipped with a touchpad that provides control of buffering, 
temperature and water change operations.  Visual and auditory alarm warnings help alert 
the user to parameters that have been exceeded.  The water treatment unit is equipped 
with prefiltration, biological filtration, fine mechanical filtration, chemical filtration and 
UV light disinfection.   Juvenile and adult frogs are provided a pellet diet, while tadpoles 
are fed a powdered yeast diet.  Room conditions are maintained at a 12:12 hour 
light:dark cycle and ambient temperature of 23ºC.  All subsequent generations were bred 
in house using chorionic gonadotropin hormone (Sigma).  Each frog used in an 
experiment was identified with an identification chip (AVID) inserted intraperitoneally 
at the time of immunization. 
 Previous literature reported euthanasia dosage in adult frogs weighing 100-125 g 
(Torreilles et al. 2009).  The average size of animal used in this immunization study was 
20-40 g.  Using tricaine methane sulfonate (MS-222), a range of concentrations was 
tested to sedate the frogs quickly, yet provide a wide safety margin against any suffering 
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before euthanasia.  Since MS-222 is acidic, the solution was buffered with phosphate 
buffered saline (PBS, 80 g of NaCl, 2.0 g of KCl, 27.2 g of Na2HPO4•7H2O, distilled 
H2O to 1L) prior to immersion of animals.  Each frog was weighed prior to submersion.  
One frog was immersed to test each dose (500 mg/L, 1 g/L, 2 g/L and 5g/L) and 
observed for movement and righting reflex at 5 minutes and 10 minutes post-immersion.  
All animals were recovered in a separate recovery tank without complications.  The 
results of this study also assisted in determination of euthanasia concentrations.  All 
frogs euthanized in MS-222 were confirmed dead with a secondary method; pithing or 
decapitation.  
 Blood collection techniques from Xenopus have not been recently published.  
Cardiac puncture, toe clipping and venous cut down are currently used methods, but for 
small 20-40 g frogs these methods are unsatisfactory for providing consistent and 
reliable samples.  To exsanguinate, frogs were heavily sedated in MS-222 and opened 
along the ventrum to expose the heart.  A small incision was made at the base of the 
heart and using a 1 ml syringe, blood was collected as it pooled.  Frogs were pithed after 
exsanguinations to verify euthanasia according to protocol Criscitiello #2008-033.   
 
2.2. Gavage Technique  
 Mice and rats are routinely gavaged using feeding needles made specific for drug 
or vehicle delivery (Table 1, adapted from Braintree Scientific).  Using this same 
technique as a model, a frog was euthanized in 5g/L of MS-222 and dissected to observe 
all major organs.   A feeding needle was inserted into the mouth and observed to pass 
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into the stomach.  We tested the technique with stainless steel and plastic feeding 
needles of various diameters and lengths (Figure 1).  During actual immunizations, the 
frogs were sedated in 2 g/L of MS-222. The bulb of the feeding needle was placed at the 
joint of the upper and lower jaw.  Slight pressure was applied to open the mouth and the 
needle directed towards the center into the stomach.  The full gavage needle was inserted 
up to the hub for proper delivery into the stomach of a 20-40 g frog (Figure 2).  
Recovery of each sedated frog was uncomplicated within 30-60 minutes in a separate 
recovery tank with regular XenoPlus system water.   
 
 
Laboratory Animal Recommended Standard Sizes 
Species 
Wgt. range 
Gauge Length Ball Dia. Shape 
in grams 
Mice 
to 14 gms 24 1" 1 1/4 mm Straight 
15-20 gms 22 1", 1 1/2" 1 1/4 mm Straight 
20-25 gms 20 1", 1 1/2",3" 2 1/4 mm Straight, Curved 
25-30 gms 18 1", 1 1/2",2" 2 1/4 mm Straight, Curved 
30-35 gms 18 2", 3" 2 1/4 mm Straight, Curved 
Rats 
50-75 gms 20 1", 1 1/2" 2 1/4 mm Straight 
75-120 gms 18 1", 1 1/2" 2 1/4 mm Straight, Curved 
100-200 gms 18 2", 3" 2 1/4 mm Curved 
 16 2" 3 mm Straight, Curved 
150-300 gms 16 3", 4" 3mm Curved 
200-350 gms 14 3" 4 mm Curved 
 13 3" 4 mm Straight 
Hamsters 60-200 gms 18 2" 2 1/4 mm Curved 
Guinea 
Pigs 
250-300 gms 18 11/2", 2 2 1/4 mm Curved 
350-450 gms 16 3", 4" 3mm Curved 
400-600 gms 14 3" 4mm Curved 
 13 3" 4mm Straight 
Rabbits 1-3 kgms 16 3", 4" 3 mm Curved 
Table 1: Standard Feeding Needle Size Recommendations. 
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 Figure 2: Placement of Feeding Needle.  Demonstration of Proper Placement of Feeding Needle for Gavage Technique.   
Figure 1: Feeding Needles. Examples of Different Sizes 
and Shapes of Feeding Needles.  
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2.3. Immunizations 
 Four sets of frogs underwent immunizations.  The first set of 10 frogs was 
comprised of three orally immunized frogs (PO), three intraperitoneally (IP) immunized 
frogs, and four non-immunized frogs (control).  The second group of 12 contained four 
PO, four IP, and four control frogs. The third group of 24 had eight PO, eight IP, and 
eight control animals. The fourth group contained 24 frogs with eight PO, eight IP, and 
eight control frogs.  Groups 1, 2 and 4 were all boosted twice after the initial 
immunization and then harvested a week after the last boost. The third set of frogs was 
immunized only once and harvested 21 days later.  Hapten dinitrophenol conjugated to 
the protein carrier keyhole limpet hemocyanin (DNP-KLH, CalBioChem) along with 
adjuvant cholera toxin, known to elicit a strong enteric mucosal immune response in 
mammals (Lycke and Holmgren 1986), comprised the immunogen.  DNP-KLH orally 
immunized frogs received 2.5 mg DNP-KLH with 10 μg of cholera toxin as adjuvant. 
Intraperitoneally immunized animals received 200 µg of antigen and 200 µl of complete 
Freund’s adjuvant for the first inoculation and 200 μg of antigen along with the same 
volume of incomplete Freund’s adjuvant for the remaining inoculations (Tables 2-5).  
Muramyl dipeptide, the key factor in Freund’s complete adjuvant has been described by 
McKenzie et.al (McKenzie and Halsey 1984). To prepare the emulsion for 
intraperitoneal injection, two 1.0 ml syringes and one 18 gauge double hub emulsifying 
needle were used.  Each aliquot was delivered aseptically into 1 ml syringe and the 
emulsifying needle attached and the second syringe connected to the opposite end of the 
needle (Figure 3). The contents were mixed by forcing the material back and forth 
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through the needle for 10 minutes. As the formation of water-in-oil emulsion is initiated, 
the solution increases in viscosity and becomes more difficult to push through the 
emulsion needle.   To test whether the emulsion is ready, a small drop of emulsion is 
placed into a beaker of water.  The drop should hold together on the surface of water if 
prepared properly.   
 
 
 
 
 
 
Figure 3: Emulsifying Needle. Demonstration of Emulsifying Needle with 
Two 1.0 ml Luer-lock Syringes for Intraperitoneal Antigen Delivery.   
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Frog ID  Route of 
Immunization Protocol  Date of Immunization  Protocol  Date of Immunization  Date of Immunization  Date of Immunization  Euthanasia  
40068609  PO  1.25 mg of 
antigen &  10 ug 
of toxin  
10/28/09  2.5  mg of 
antigen &  10 ug 
of toxin  
11/4/09  11/12/09  11/20/09  12/9/09  
40106305 PO  1.25 mg of 
antigen &  10 ug 
of toxin 
10/28/09 2.5 mg of 
antigen &  10 ug 
of toxin  
11/4/09 11/12/10 11/20/09 12/9/09 
40094344  PO  1.25 mg of 
antigen and 10 
ug of toxin  
10/28/09 2.5 mg of 
antigen &  10 ug 
of toxin  
11/4/09 11/12/10 11/20/09 12/9/09 
40061336  IP  200 ug of antigen 
& 200 ul of CFA  
10/28/09 200 ug of 
antigen & 200 ul 
of IFA  
11/4/09 11/12/10 11/20/09 12/9/09 
40106346  IP  200 ug of antigen 
& 200 ul of CFA  
10/28/09 200 ug of 
antigen & 200 ul 
of IFA  
11/4/09 11/12/10 11/20/09 12/9/09 
40062790  IP  200 ug of antigen 
& 200 ul of CFA 
10/28/09 200 ug of 
antigen & 200 ul 
of IFA  
11/4/09 11/12/10 11/20/09 12/9/09 
40097857  control No treatment  10/28/09 No treatment 11/4/09 11/12/10 11/20/09 12/9/09 
40072280  control  No treatment 10/28/09 No treatment 11/4/09 11/12/10 11/20/09 12/9/09 
40106625 control  No treatment 10/28/09 No treatment 11/4/09 11/12/10 11/20/09 12/9/09 
40065537  control  No treatment 10/28/09 No treatment 11/4/09 11/12/10 11/20/09 12/9/09 
Table 2: First Group of Immunizations. Immunization Protocol, Routes and Dates of Immunization. 
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Frog ID  Route of 
Immunization Protocol  Date of Immunization  Protocol  Date of Immunization  Date of Immunization  Date of Immunization  Euthanasia  
48528626  PO  1.25 mg of 
antigen & 10 ug 
of toxin  
4/2/10  1.25 mg of 
antigen & 10 ug 
of toxin  
4/10/10  4/16/10  4/22/10  5/3/10  
48529873  PO  1.25 mg of 
antigen & 10 ug 
of toxin  
4/2/10  1.25 mg of 
antigen & 10 ug 
of toxin  
4/10/10 4/16/10  4/22/10  5/3/10  
48540782 PO  1.25 mg of 
antigen & 10 ug 
of toxin  
4/2/10 1.25 mg of 
antigen & 10 ug 
of toxin  
4/10/10  4/16/10  4/22/10  5/3/10  
48548547 PO  1.25 mg of 
antigen & 10 ug 
of toxin  
4/2/10 1.25 mg of 
antigen & 10 ug 
of toxin  
4/10/10 4/16/10  4/22/10  5/3/10  
48543284 IP  200 ug of antigen 
& 200 ul of CFA  
4/2/10 200 ug of antigen 
& 200 ul of IFA  
4/10/10  4/16/10  4/22/10  5/3/10  
48530549   IP  200 ug of antigen 
& 200 ul of CFA  
4/2/10 200 ug of antigen 
& 200 ul of IFA  
4/10/10  4/16/10  4/22/10  5/3/10  
48523067 IP 200 ug of antigen 
& 200 ul of CFA  
4/2/10 200 ug of antigen 
& 200 ul of IFA  
4/10/10  4/16/10  4/22/10  5/3/10  
40075638 IP  200 ug of antigen 
& 200 ul of CFA  
4/2/10 200 ug of antigen 
& 200 ul of IFA  
4/10/10  4/16/10  4/22/10  5/3/10  
40083849 control  No treatment 4/2/10 No treatment 4/10/10  4/16/10  4/22/10  5/3/10  
40086381 control  No treatment 4/2/10 No treatment 4/10/10  4/16/10  4/22/10  5/3/10  
40069038 control  No treatment  4/2/10 No treatment  4/10/10 4/16/10  4/22/10  5/3/10  
40101269 control  No treatment  4/2/10 No treatment  4/10/10 4/16/10  4/22/10  5/3/10  
Table 3: Second Group of Immunizations. Immunization Protocol, Routes and Dates of Immunization.   
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Frog ID Route of Immunization Protocol 
Date of 
Immunization Euthanasia 
48531097 
 
PO  1.25 mg of antigen & 10 ug of 
toxin  
7/9/10  7/30/10  
48539881  PO  1.25 mg of antigen & 10 ug of 
toxin  
7/9/10 7/30/10  
45829561 IP  200 ug of antigen & 200 ul of CFA  7/9/10 7/30/10 
48531588 IP  200 ug of antigen & 200 ul of CFA  7/9/10 7/30/10 
48531614 control  No treatment  7/9/10 7/30/10 
48513618 control  No treatment  7/9/10 7/30/10 
48532124  PO  1.25 mg of antigen & 10 ug of 
toxin  
7/24/10  8/13/10  
48538598  PO  1.25 mg of antigen & 10 ug of 
toxin  
7/24/10 8/13/10 
48526365  IP  200 ug of antigen & 200 ul of CFA  7/24/10 8/13/10 
48528096  IP  200 ug of antigen & 200 ul of CFA  7/24/10 8/13/10 
48529602  control  No treatment  7/24/10 8/13/10 
48539258  control  No treatment  7/24/10 8/13/10 
Table 4: Third Group of Immunizations. Immunization Protocol, Routes and Dates of 
Immunization 
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Frog ID Route of Immunization Protocol 
Date of 
Immunization Euthanasia 
48513570 PO  1.25 mg of antigen & 10 ug of 
toxin  
7/17/10 8/7/10  
48550035 
 
PO  1.25 mg of antigen & 10 ug of 
toxin  
7/17/10 8/7/10 
48520345 
 
IP  200 ug of antigen & 200 ul of 
CFA  
7/17/10 8/7/10 
48380006 
 
IP  200 ug of antigen & 200 ul of 
CFA  
7/17/10 8/7/10 
48541370 
 
control  No treatment  7/17/10  8/7/10 
48556023 
 
control  No treatment  7/17/10 8/7/10 
48371074  PO  1.25 mg of antigen & 10 ug of 
toxin  
7/25/10  8/15/10  
48518356  PO  1.25 mg of antigen & 10 ug of 
toxin  
7/25/10 8/15/10 
48534321  IP  200 ug of antigen & 200 ul of 
CFA  
7/25/10 8/15/10 
48531545  IP  200 ug of antigen & 200 ul of 
CFA  
7/25/10 8/15/10 
48532776  control  No treatment  7/25/10 8/15/10 
48371541  control  No treatment  7/25/10 8/15/10 
Table 4, continued. 
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Frog ID Immunization 
Route 
Protocol Date of 
Immunization 
Date of 
Immunization 
Date of 
Immunization 
Euthanasia 
48519538 control No treatment    10/25/10 
48514844 control No treatment    10/25/10 
48532305 control No treatment    10/28/10 
48372541 control No treatment    10/28/10 
48375553 control No treatment    11/12/10 
48543086 control  No treatment     11/12/10 
48372549 control No treatment    11/18/10 
48541798 control No treatment    11/18/10 
48530376 IP 200 ug of antigen & 200 ul of CFA  9/27/10 10/7/10 10/15/10 10/25/10 
48554635 IP 200 ug of antigen & 200 ul of CFA  9/27/10 10/7/10 10/15/10 10/25/10 
48531096 IP 200 ug of antigen & 200 ul of CFA  9/30/10 10/7/10 10/15/10 10/25/10 
48372843 IP 200 ug of antigen & 200 ul of CFA  9/30/10 10/7/10 10/15/10 10/25/10 
Table 5: Fourth Group of Immunizations.  Immunization Protocol, Routes and Dates of Immunization. 
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Frog ID Immunization 
Route 
Protocol Date of 
Immunization 
Date of 
Immunization 
Date of 
Immunization 
Euthanasia 
48532104 IP 200 ug of antigen & 200 ul of CFA  10/7/10 10/15/10 10/22/10 10/28/10 
48547374 IP 200 ug of antigen & 200 ul of CFA  10/7/10 10/15/10 10/22/10 10/28/10 
48549615 IP 200 ug of antigen & 200 ul of CFA  10/7/10 10/15/10 10/22/10 10/28/10 
48522564 IP 200 ug of antigen & 200 ul of CFA  10/7/10 10/15/10 10/22/10 10/28/10 
48537869 PO 2.5 mg of antigen & 10 ug of cholera  10/15/10 10/22/10 10/29/10 10/25/10 
48528266 PO 2.5 mg of antigen & 10 ug of cholera  10/15/10 10/22/10 10/29/10 10/25/10 
56271587 PO 2.5 mg of antigen & 10 ug of cholera  10/18/10 10/25/10 11/01/10 10/28/10 
56265593 PO 2.5 mg of antigen & 10 ug of cholera  10/18/10 10/25/10 11/01/10 10/28/10 
56114074 PO 2.5 mg of antigen & 10 ug of cholera  10/18/10 10/25/10 11/01/10 11/12/10 
56276019 PO 2.5 mg of antigen & 10 ug of cholera  10/18/10 10/25/10 11/01/10 11/12/10 
56278127 PO 2.5 mg of antigen & 10 ug of cholera  10/21/10 10/28/10 11/04/10 11/18/10 
56272568 PO 2.5 mg of antigen & 10 ug of cholera  10/21/10 10/28/10 11/04/10 11/18/10 
Table 5, continued. 
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2.4. ELISA  
The purpose of the enzyme-linked immunoassay was to compare total Ig made 
by gut and spleen B cells of immunized frogs to non-immunized frogs regardless of 
antigen specificity (Figure 4).  Serum was separated from whole blood collected from 
frogs.   Using a 96 U well microtiter plate (BD Falcon), 100 μl of serial diluted (1:101 to 
1:1011, Figure 5) frog sera of one frog was placed in each row.  Amphibian phosphate 
buffer saline (a-PBS, 65% 1X PBS and 35% de-ionized water), mammalian PBS 
adjusted for amphibian homeostatic salt, was added to the last column as control (Figure 
6).  The plate with sera was incubated at 37ºC for 1 hour. The contents of the plate were 
dumped, washed twice with a-PBS, blotted dry on clean paper towels and blocked with 
2% casein overnight at 4ºC.  Anti-Xenopus Ig hybridomas and the properties of their 
products have been described by Hsu 1984 at the Basel Institute for Immunology, Basel, 
Switzerland. Monoclonal antibodies 10A9, 14A11 and 14G1 are against heavy chain 
IgM.  Antibodies 4110D5, 4110B3 and 408A10 are directed against IgX and 11D5 
against IgY (Hsu and Du Pasquier 1984).  The next day the plate was washed with PBS 
and 100 μl of mouse anti-frog IgM hybridoma supernatant (10A9) or IgX (408A10) at 
1:100 dilution was added to all wells except the row with no primary antibody.  The 
plate was incubated overnight at 4ºC.  ELISA controls that contained no primary (IgM, 
10A9) or no secondary antibodies (sheep anti-mouse IgG conjugated to horseradish 
perioxidase) were selected from the immunized group.  100 μl of sheep anti-mouse IgG 
conjugated to horseradish perioxidase (Sigma) was added after washing with PBS except 
for rows without secondary antibody.  After incubation for an hour at room temperature, 
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the plate was washed twice with a-PBS and dried.  3, 3’, 5, 5’-Tettramethylbenzidine 
(TMB, Sigma) substrate solution was made by dissolving one tablet in 1 ml of DMSO 
and adding 9 ml of 0.05 M phosphate-citrate buffer, pH 5.0 (Sigma).  Two μl of 30% 
hydrogen peroxide (EMD Chemicals USA) per 10 ml of substrate buffer solution was 
added immediately prior to use.  The reaction was stopped by the addition of 100 μl of 2 
M H2SO4 (BDH Aristar, 13.9 ml of 18 M stock H2SO4 solution was diluted in 86 ml of 
de-ionized water to prepare a 2 M solution) per well. Absorption was detected at 450 nm 
using an iMark Microplate Absorbance Reader (Bio-Rad).   
 
 
 
Figure 4: Total ELISA Protocol Diagram. 
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Figure 5: Total ELISA Protocol Serial Dilutions. Serum Titrations 
from 1:101 to 1:1011 and PBS as Control. 
Figure 6: Total ELISA Protocol Plate Set-Up. Organization of Plate with 
Two PO, Two IP, Two Control Non-immunized, and Two ELISA 
Controls. 
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The second ELSA protocol was designed for measurement of antigen specific 
antibodies of a particular isotype.  It started with 100 μl of 1 μg/ml DNP-KLH in each 
well (Figure 7).  The plate was incubated at 37ºC for one hour, washed twice with PBS, 
and blocked with 2% casein overnight at 4ºC. The next day, after washing twice with 
PBS,  Xenopus sera diluted from 1:3 to 1:243 were added to the wells and incubated for 
2 hours at 37ºC (Figure 8).  After washing with PBS, 100 μl of IgM (10A9) or IgX 
(4110B3) at a 1:100 dilution was added to all wells except the no primary antibody rows 
and the plate incubated overnight at 4ºC.  Again as described in the first protocol, ELISA 
controls that contained no primary or no secondary antibodies were selected from the 
immunized group (Figure 9).  Next, 100 μl of sheep anti-mouse IgG conjugated to 
horseradish perioxidase was added after washing with PBS except for rows without 
secondary antibody.  This was then incubated for an hour at room temperature and after 
washing twice with PBS.  3, 3’, 5, 5’-Tetramethylbenzidine substrate solution was made 
by dissolving one tablet in 1 ml of DMSO and adding 9 ml of 0.05 M phosphate-citrate 
buffer, pH 5.0.  Next, 2 μl of 30% hydrogen peroxide per 10 ml of substrate buffer 
solution was added immediately prior to use.  The reaction was stopped by addition of 
100 μl of 2 M H2SO4 per well.  Absorption was detected at 450 nm using an iMark 
Microplate Absorbance Reader.    
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  Figure 8: Antigen-Specific ELISA Protocol Serial Dilutions.  Serum 
Titrations 1:3 to 1:35 and PBS as Control. Multiple Samples Can Be 
Run Simultaneously.  
Figure 7: Antigen-Specific ELISA Protocol Diagram. 
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2.5 Phylogenetic Analysis    
 A set of amino acid sequences of immunoglobulin heavy proteins in non-
mammalian tetrapods was compiled (Table 6).  Alignments were initially made in 
Bioedit with ClustalW employing gap opening penalties of 10 and gap extension 
penalties of 0.1 for pairwise alignments, then 0.2 for multiple alignments and the protein 
weighting matrix of Blossum. Default alignment parameters were used.  These 
alignments were then modified by hand, especially the entire C region alignment in 
making sure most homologous C regions were aligned to one another.  MEGA was used 
to infer the phylogenetic relationships of immunoglobulin C regions and individual C 
domains.  Neighbor-joining consensus trees were made from 1000 bootstrap replicates, 
Figure 9: Antigen-Specific ELISA Protocol Plate Set-Up. 
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using pairwise deletion and collapsing internal nodes with less than 50% bootstrap 
support.   
 
 
 
Common Name Species 
Tree 
Abbreviation 
Example 
Ig C Protein 
Nurse shark Ginglymostoma cirratum M C1 shark IgM 4 AAT76789.1 
Zebrafish Danio rerio M C1 zebrafish IgM 4 AAT67447.1 
    T C1 zebrafish IgT 3 AAT67446.1 
Rainbow trout Oncorhynchus mykiss M C1 trout IgM 4 AAW66972 
    T C1 trout IgT 4 AAW66981.1 
Fugu Takifugu rubripes H fugu IgH 2 BAD89297 
Iberian ribbed newt Pleurodeles waltl M C1 newt IgM 4 CAE02685 
    X C1 newt IgX/P 4 CAL25718 
    Y C1 newt IgY 4 CAE02686 
Mexican axolotl  Ambystoma mexicanum M C1 axolotl IgM 4 A46532 
    X C1 axolotl IgX 4 CAO82107.1 
    Y C1 axolotl IgY 4 X69492 
African clawed frog Xenopus laevis M C1 frog IgM 4 AAH84123 
    X C1 frog IgX 4 S03186 
    Y C1 frog IgY 4 AAH97629 
African clawed frog Xenopus tropicalis F C1 frog IgF 2 MGC108125 
Red-eared slider 
Trachemys scripta 
elegans M C1 slider IgM 4 AAB03838 
Chinese soft-shelled 
turtle Pelodiscus sinensis M C1 turtle IgM 4 ACU45376.1 
    Y C1 turtle IgY 4 ACU45374.1 
Green anole Anolis carolinensis M C1 anole IgM 4 ABV66128 
    Y C1 anole IgY 4 ABV66132 
Leopard gecko Eublepharis macularius M C1 gecko IgM 4 ABY74510.1 
    A C1 gecko IgX/A 4 ABG72684.1 
    Y C1 gecko IgY 4 ACF60235.1 
Duck Anas platyrhynchos M C1 duck IgM 4 AAA68605.1 
    A C1 duck IgA 4 AAA68606.1 
    Y C1 duck IgY 4 CAA46322.1 
Table 6: List of Species Used to Generate Alignments. 
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Common Name Species 
Tree 
Abbreviation 
Example 
Ig C Protein 
Common pheasant Phasianus colchicus M C1 pheasant IgM 4 PMID 20398946 
    A C1 pheasant IgA 4 PMID 20398946 
    Y C1 pheasant IgY 4 PMID 20398946 
Turkey Meleagris gallopavo M C1 turkey IgM 4 PMID 20398946 
    A C1 turkey IgA 4 PMID 20398946 
    Y C1 turkey IgY 4 PMID 20398946 
Quail Coturnix japonica M C1 quail IgM 4 PMID 20398946 
    A C1 quail IgA 4 PMID 20398946 
    Y C1 quail IgY 4 PMID 20398946 
Chicken Gallus gallus M C1 chicken IgM 4 P01875 
    A C1 chicken IgA 4 AAB22614.2 
    Y C1 chicken IgY/G 4 S00390 
Australian echidna Tachyglossus aculeatus M C1 echidna IgM 4 AAN33013.1 
    A C1 echidna IgA 3 AAN33012.1 
    G C1 echidna IgG 3 AAM61760.1 
Platypus Ornithorhynchus anatinus M C1 platypus IgM 4 AAO37747.1 
    A1 C1 platypus IgA1 3 AAL17700.1 
    A2 C1 platypus IgA2 3 AAL17701.1 
    Y C1 platypus IgY/O 4 ACD31541   
    G1 C1 platypus IgG1 3 AAL17703.1 
    G2 C1 platypus IgG2 3 AAL17704.1 
Gray short-tailed 
opossum Monodelphus domestica M C1 opossum IgM 4 AAD24482.1 
    A C1 opossum IgA 3 AAC48835.1 
    G C1 opossum IgG 3 AAC79675.1 
Mouse Mus musculus M C1 mouse IgM 4 AAB59651.1 
    A C1 mouse IgA 3 AAB59662.1 
    G C1 mouse IgG 3 AAB59656 
Human Homo sapiens M C1 human IgM 4 CAA33070    
    A1 C1 human IgA 3 AAC82528.1 
    G1 C1 human IgG1 3 AAC82527.1 
Table 6, continued.  
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2.6 Ig Heavy/Ig Light Isotype Relationships 
 B cells were sorted based on IgL isotype using MACS magnetic cell sorting 
system (Miltenyi Biotec). Spleens were disassociated using a wire mesh with 1 ml of a-
PBS, spun down and washed with MACS buffer [0.5% BSA (0.5g/100 ml) and 2mM 
EDTA (400 ug/100ml) into a-PBS].  After the supernatant was removed the B cells were 
resuspended in 1 ml of MACS a-PBS for counting. Since direct MicroBeads were not 
commercially available for frog immunoglobulins, the indirect magnetic cell labeling 
protocol for MACS was followed. The splenic B cells were spun down after counting 
and labeled with primary antibody in 1:2 dilutions for 1 hour at 4ºC.  Cells were washed 
by adding 2 ml of buffer, spun down and the supernatant removed.  This was repeated.  
In a second step, cells are magnetically labeling with MACS Microbeads.  Anti-mouse 
IgG microbeads (20 μl) was added to 80 μl of resuspended cells and allowed to incubate 
for 15 minutes at 4ºC. After washing, cells were resuspended in 500 μl of MACS buffer. 
Positively labeled cells were separated following the positive selection strategy for 
MACS (Figure 10).  A column is suspended onto a magnetic and the labeled and 
unlabeled cell suspension is added.  The column is flushed with 3 ml of MACS buffer 
three times. The desired magnetically labeled cells remain in the column as cells 
negative for primary antibody flow through and are collected. These negative cells are 
used as control. The column is removed from the magnet and the positively labeled cells 
are flushed through the column and counted for comparison prior to labeling. 
Approximately 50,000 positively labeled cells were recovered using MACS sorting.   
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Using RNeasy (Qiagen), RNA was purified from the positively collected cells.   
Buffer RLT (350 μl) was used to resuspend the pelleted cells.  A 20 gauge needle was 
fitted to an RNase-free syringe and the cells were lysed by passing through the needle 
repeatedly.  One volume of 70% ethanol was added to the lysate and pipetted to mix and 
700 μl of sample was transferred to an RNeasy column and centrifuged for 15 s at 
10,000 rpm.  The flow-through was discarded and 350 μl of Buffer RW1 was then added 
to the column and centrifuged for 15 s at 10,000 rpm and flow through discarded.  Then 
10 μl of DNase I stock solution was added to 70 μl of Buffer RDD and mixed by 
inverting the bottle.  The 80 μl was added to the RNeasy column and incubated at room 
temperature for 15 minutes. Buffer RW1 (350 μl) was then added to the column and 
Figure 10: MACS Cell Sorting System. Photo Depicts 
Adding Cell Suspension into Column.  Collected Cells Will 
Be Negatively Labeled and Used as Control.   
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centrifuged for 15 seconds at 10,000 rpm and flow through discarded. 500 μl of Buffer 
RPE was added to the column and centrifuged for 15 seconds at 10,000 rpm.  The flow 
through was discarded.  The spin column was placed in a new collection tube and 30-50 
μl of RNase-free water was added and centrifuged for 1 min at 10,000 rpm to elute the 
RNA.   Confirmation of RNA was performed using a nanodrop spectrophotometer. RNA 
was either stored in -80ºC or immediately converted to first-strand cDNA (Invitrogen).  
For first strand cDNA synthesis, 5 μg of total RNA, 1 μl of random hexamer 
primer, 1 μl of 10mM dNTP mix, and DEPC-treated water were combined to make a 
total 10 μl solution in a 0.5 ml PCR tube.  This was incubated at 65ºC for 5 minutes and 
immediately placed on ice for 1 minute.   cDNA synthesis mix (2 μl of 10X RT buffer, 4 
μl of 25mM MgCl2, 2 μl of 0.1 M DTT, 1 μl of RNase OUT, 1 μl of SuperScript) was 
prepared by adding each component in the indicated order.  cDNA synthesis mix (10 μl) 
was added to the RNA/pimer mixture, mixed gently and centrifuged briefly.  The 
mixture was incubated for 10 minutes at 25ºC and immediately for 50 minutes at 50ºC. 
The reaction was terminated at 85ºC for 5 minutes and chilled on ice and1 μl of RNase H 
was added and incubated for 20 minutes at 37ºC.  cDNA can be stored at -20ºC or used 
for PCR immediately.   
cDNA results were tested using PCR with primers to the conserved WYRK motif 
and reverse primers to the N-terminal domains of the three IgH constant genes made by 
Invitrogen (Table 7).  Master mix for PCR consisted of 10 μl of 5X buffer, 1 μl of dNTP 
(10mM), 1 μl of front and rear primers (10 mM), 5 μl of template (positive or negative), 
and 0.25 μl of Taq polymerase.  Water was added to total a 50 μl mix. The gel prep 
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consisted of 0.4 g of UltraPure agarose, 60 ml of 1X TAE and 2.7 μl of gel green dye.  
The agarose was added to a 250 ml beaker, covered with plastic wrap and heated in the 
microwave for 1:30 minutes, making sure the solid dissolved.  Gel green dye (2.7 μl) 
was added to the heated solution and stirred gently.  The beaker was allowed to cool 
before pouring into a small gel cast with 1.5 mm ten tooth comb.   
 
 
Code Name 5'-3' Sequence  TM C 
MFC 201 X1 IgM C3 F1 AACACACAGCTGGCTTCA 58.4 
MFC 202 X1 IgM C4 R1 AGCATCTCAAGGTGGCAGTT 58.4 
MFC 203 X1 IgX C3 F1 GTGTTTGTGCTGAGGTGGCAGTT 60.5 
MFC 204 X1 IgX C4 R1 TAGTTCTTGAGCGGATGGTG 58.4 
MFC 205 X1 IgY C3 F1 CACCCTGATCTTCCATCACC 60.5 
MFC 206 X1 IgY C4 R1 TAAAGATTAAGTAGTAGA 42.4 
MFC 207 X1 IgY C4 R2 GTCGTACGTATTCTG 43.5 
MFC 208 X1 IgY C4 R3 CTATAGAACCCCACACTTC 55 
 
Table 7: Primers Used for PCR. 
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3. RESULTS 
 
 
3.1 Development of Frog Experimental Techniques 
 The optimal sedation concentration for the young post-metamorphosis frogs was 
2 g/L of MS-222 buffered solution.  At 2 g/L, frogs ranging from 20-40 g were 
adequately sedated to handle without extensive animal movement which minimized 
trauma and risk of dropping. Sedation was adequate at 10 minutes, but not at 5 minutes 
duration which was assessed by cessation of movement, especially swimming motion of 
the rear feet and delayed righting reflex if turned over.  At 500 mg/L and 1g/L, the frogs 
continued to move 20-30 minutes after immersion.  At 5 g/L, some frogs stopped 
moving after 2 minutes and the righting reflex returned after 60 minutes in the recovery 
tanks.  Based on this finding, it was determined to be an adequate euthanasia dose (Table 
8).   
 
Frog 
ID 
Weight 
(g) 
Concentration 
(g/L) 
Time to sedation 
(min) 
1 20 0.5 25 
2 28 1 > 30 
3 22 2 10 
4 26 5 2 
 
 
Blood collection by cardiac exsanguination was a quick, reliable method of 
collecting 1.0-1.5 ml of blood from each frog.  Cardiac puncture, venous cut-down and 
toe-clipping did not result in consistent blood volume collection.  Problems in the first 
Table 8: Results of MS-222 Sedation. 
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and second groups of immunizations included hemolysis and clotting, but were not 
issues in the 3rd and 4th groups of immunizations.   
 
3.2 Gavage Technique  
The optimal method of antigen delivery was empirically determined to be with a 
20 gauge 1.5 inch stainless steel feeding needle (Figure 11). Although longer stainless 
steel and disposable plastic gavage needles were adequate for the demonstration during 
necropsy, they were too flexible for ease of guidance in the mouth at the commissure of 
the jaw (Table 9).  Also, a more heavily sedated frog was ideal for antigen delivery. The 
jaw and swallow reflex were still intact in sedated frogs immersed in 2 g/L MS-222 at 10 
minutes and antigen delivery was not consistent (Figure 12). Frogs sedated for 
approximately 15 minutes, relaxed their jaw and allowed insertion of the feeding needle 
and proper delivery of antigen.   
 
 
 
Needle length (inches) Material Sedation (minutes) 
3 1.5 Stainless steel Plastic  15 10 
- + + - + - 
 
Table 9: Comparison of Feeding Needle Material, Length and 
Frog Sedation. 
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 Figure 11: Placement of Feeding Needle. The Ball of the Needle Can Be Seen Through the 
Stomach.  (The Stomach Has Been Opened to 
Demonstrate Placement). 
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3.3 Immunizations 
 The duration of sedation was not sufficient for the first group of frogs.  Oral 
innoculant leaked out of some frogs’ mouths. Approximately, 50% of frogs did not 
receive the complete oral dose.  It was also difficult to open the mouth to guide the 
feeding needling down into the stomach.  The increase in sedation aided in animal 
handling and feeding needle delivery, but spontaneous regurgitation and leakage of 
antigen/adjuvant continued in the second group with approximately 50% of oral 
immunization failure.  The second set of frogs developed granulomas in the peritoneum 
presumably as a consequence of intraperitoneal injections.  This was not seen in any 
other group of animals or recorded in literature.  It was then proposed that the DNP-
KLH the second group of frogs was injected with was contaminated. It had a rancid 
Figure 12: Antigen Leaking Out of Frog.  A Picture Showing 
Antigen Leaking Out of the Mouth of a Lightly Sedated Frog.   
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sulfur-like smell. Subsequent bottles of lyophilized powder were reconstituted with de-
ionized water, aliquoted and stored in -20ºC.   Due to this granuloma finding the third set 
of frogs was only given the initial immunization and harvested three weeks later.  No 
lesions were found prior to blood collection. In the third group, slightly larger frogs were 
used (30-40 g). Oral immunizations in the third group only had ~20% of leakage of 
antigen/adjuvant.  The rational was that they had a larger stomach and could hold more 
volume. Increasing the concentration of the DNP-KLH and decreasing the dose further 
assisted in orally antigen delivery in the fourth and last group.    The fourth group of 
frogs was immunized with less volume, more concentrated antigen, more heavily 
sedated and boosted two more times than the third group before harvest.  No antigen 
leaked out of the mouth.  No lesions were observed during harvest.  The concentration of 
antigen intraperitoneally immunized remained the same as originally stated in materials 
and methods throughout the immunization schedule for all groups. A summary is 
provided in Table 10.  
 
 
Group 
Length of 
sedation 
Larger 
frog 
Concentrated 
antigen  
Antigen leaked 
out 
1 - - - + 
2 + - - + 
3 + + - + 
4 + + + - 
 
 
 
Table 10: Summary of Group, Sedation, Concentration and 
Immunizations.    
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3.4 ELISA 
Dissolving the TMB tablets in DMSO and phosphate-citric buffer solution was a 
challenge in the initial ELISA trials.  Even after several hours, the tablet remained intact 
in the solution.  Crushing the tablet would leave flakes of TMB in solution.  This causes 
uneven color change and high well absorbance in certain wells.  Eventually, the protocol 
was established to leave the tablet in 1 ml of DMSO in a 15 ml centrifuge tube and to 
incubate it at 37ºC for 10 minutes and pulse vortex a few times to remove any flakes of 
TMB.  This method took less than 15 minutes to completely dissolve the tablet.  Nine ml 
of citric phosphate buffer was then added to the dissolved tablet-DMSO solution. Two μl 
of H2O2 was added immediately prior to plating to complete the TMB substrate solution.   
The first ELISA protocol (measuring total relative levels of a particular isotype) 
used frog serum in a 1:10 dilution as the primary antigen. The purpose of this protocol 
was to test for changes in total response of IgM or IgX due to immunization through a 
particular route.  Twenty eight samples were tested: nine orally immunized frogs, nine 
systemically immunized frogs and 10 control non-immunized animals.  Six frogs in the 
third group were not tested. This decision was based on the results of the first eighteen 
animals and was made to conserve serum for future testing. Only the first three groups 
were tested using the first ELISA protocol.  Results showed no significant difference 
between non-immunized controls and orally immunized and intraperitoneally 
immunized frog, although there was a higher systemically immunized response than oral 
or control IgM response in much of the titrating portion of the curve (Table 11, Figure 
13).  ELISA controls were as expected. 
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1:10 1:102 1:103 1:104 1:105 1:106 1:107 1:108 1:109 1:1010 1:1011 PBS 
IgM Avg 
PO 
0.331 0.284 0.337 0.343 0.321 0.201 0.144 0.12 0.089 0.082 0.075 0.077 
IgM Avg 
IP 
0.272 0.289 0.289 0.29 0.294 0.177 0.119 0.113 0.094 0.087 0.071 0.073 
IgM Avg 
cntrl 
0.32 0.303 0.334 0.382 0.307 0.201 0.175 0.13 0.132 0.158 0.078 0.091 
   
 
 
 
 
 
Figure 13: IgM Group 1 Total Ig ELISA Protocol. 
Table 11: Average IgM Group 1 Total ELISA Protocol.   
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Results for the IgX total ELISA for the first immunized group showed induction 
of IgX after oral immunization, not seen in the IP group (Table 12, Figure 14). This is an 
exciting finding because I hypothesized that IgX, a proposed analog of IgA, would be 
specifically produced with oral immunization compared to systemic immunization. This 
is the first evidence that oral immunization of Xenopus elicits an IgX response, 
consistent with the idea that it is (like our IgA) a dedicated mucosal isotype.  Only the 
first group of immunized frogs had an increased oral response.  The response was not 
seen in the second group, where oral responses were lower than intraperitoneal or 
control non-immunized responses. Group 4 was not tested for IgX using the first ELISA 
protocol.   
 
 
 
1:10 1:102  1:103  1:104  1:105  1:106  1:107  1:108  1:109  1:1010  1:1011  PBS 
IgX Avg 
PO 
0.294 0.364 0.323 0.291 0.218 0.201 0.205 0.212 0.155 0.119 0.096 0.1 
IgX Avg 
IP 
0.211 0.188 0.198 0.179 0.195 0.131 0.142 0.167 0.156 0.121 0.091 0.094 
IgX Avg 
cntrl 
0.199 0.231 0.212 0.189 0.194 0.201 0.165 0.171 0.158 0.126 0.109 0.097 
 
 
Table 12: Average IgX Group 1 Total ELISA Protocol.   
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The second ELISA protocol, using DNP-KLH as the primary antigen, tested for a 
specific response to DNP-KLH instead of total IgM or IgX levels in serum.  A total of 
18 orally immunized, 18 intraperitoneally immunized and 18 non-immunized frog serum 
samples were compared by this ELISA.  This set of ELISA experiments had nine no 
primary antibody controls and nine no-secondary controls.  Some samples were omitted 
due to insufficient serum for dilution (Table 13).  
 
 
 
 
Figure 14: IgX Group 1 Total Ig ELISA Protocol. 
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48371074 PO 
48518356 PO 
48534321 IP 
48531545 IP 
48532776 Control 
48371541 Control 
 
 
In the first two immunized groups, all frogs did not receive the full antigen dose.  
This may have resulted in a poor oral response compared to control and systemic 
immunization in both groups.  However, in the third group, there were fewer frogs that 
refused the oral immunization and a stronger oral response is seen compared to systemic 
and control (Figure 15).  Also there is no significance between systemic and control.  
The fourth immunization is stronger on the Y axis due to a full immunization with the 
concentration increased and the dose decreased.  Again oral immunization is significant 
over control and systemic immunizations.  The average of all four immunizations is 
show in Table 14 and Figure 16 and shows a significant increase in systemic IgM serum 
levels in the intraperitoneally injected group of animals compared to IgM serum levels of 
orally immunized animals and non-immunized animals. However, there was no 
significance for IgX Ag-specific ELISA.  In fact, immunized groups 1-3 showed no 
correlation between orally immunized, intraperitoneally immunized or control animals 
(Figures 17-18).  The no primary and no secondary controls were as expected.   
Table 13: Omitted Frogs from Antigen-specific ELISA 
Protocol. 
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0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Avg control
Avg IP
Avg PO
Figure 15: IgM Group 3 Antigen-specific 
ELISA Protocol. Average IP Has 
Significantly Higher Response Than Oral or 
Control Animals.  
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0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
Avg of control
Avg of IP
Avg of PO
Serum dilution 1/9 1/10 1/27 1/81 1/243 PBS 
Avg of control 0.518333 0.51425 0.440611 0.341833 0.286667 0.195333 
Avg of IP 0.6485 0.640833 0.547333 0.455389 0.394 0.191944 
Avg of PO 0.533167 0.53275 0.458833 0.361 0.303111 0.176889 
Avg of no primary 0.164667 0.181333 0.191222 0.189222 0.175444 0.165 
Avg of no secondary 0.087333 0.1055 0.094778 0.091111 0.090667 0.092778 
Table 14: IgM Average Data for Antigen-specific ELISA Protocol.   
Figure 16: IgM Average Antigen-specific ELISA Protocol. 
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0
0.1
0.2
0.3
0.4
0.5
0.6
Avg PO
Avg IP
Avg control
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
0.5
Avg PO
Avg IP
Avg control
Figure 18: IgX Group 4 Antigen-specific ELISA Protocol.  
Figure 17: IgX Group 3 Antigen-specific ELISA Protocol. 
46 
 
 
46 
3.5 Phylogenetic Analysis 
 Results of ELISA showed that oral immunization elicits an IgX response.  To 
support my hypothesis further, we wanted to combine this physiological data with 
comparative immmunogenetics analyses. Immunoglobulin heavy chain C region 
sequences from other animals may help inform us of the relationship between frog IgX 
and human IgA.  Recent research in several higher vertebrates suggested that we should 
revisit the natural history of these immunoglobulin heavy chain C region loci, as a more 
representative phylogeny could now be created. .  For example, in Choi et al 2010a, the 
authors looked at pheasant, turkey and quail heavy chain genes and found that avian IgA 
is more closely associated with mammalian IgA than previously believed (Choi et al. 
2010a).  This analysis used the complete C region from C1 to C4 depending on species.  
Transmembrane or secreted domains were not included in this analysis. Our C region 
tree analysis shows a tree of the C regions of many isotypes from sharks to man.  
Looking at the data from IgX and IgA of bird and mammal (Figures 19-20), IgX did not 
cluster with IgM. Unlike what was found in any previous phylogeny, IgX and IgA were 
closely related.   
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Figure 19: Constant Region Tree. 
 
 
 
48 Figure 20: Closer Look at Constant Region Tree.  
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The recent divergence of IgX and IgA is an unheralded finding and the tree 
suggests that IgM gave rise to IgX that gave rise to IgA. Physiologically, the data in this 
project show that oral immunization gave rise to an IgX immune response. Secondly this 
tree suggests that IgX is more closely related to IgA than to any other isotype, with high 
statistical support depicted in the 99 bootstrap value at the node linking them. Sequence 
identity and reactivity to oral immunization are shared suggesting that IgA and IgX may 
actually be of same clan, but more work is needed to support this idea. This story may 
prove to be similar to how shark IgW has been reclassified as IgD. In that case it also 
took a more complete phylogeny to “connect the dots”.  Similar results were attained by 
maximum parsimony, although neighbor-joining produced greater statistical support.   
 
3.6 Ig Heavy/Ig Light Isotype Relationships  
 To see if Ig light chain in Xenopus has a preference for Ig heavy chain, Xenopus 
B cells from spleen were sorted using MACS system.  For the first PCR, only κ and σ 
positive and negative cells were tested against IgM, IgX and Igκ primers.  For κ 
negatively sorted cells, there were positive bands with IgM, IgX and Igκ primers as 
expected.  For κ positively sorted cells, we expected a positive band with IgM primer 
and a cleaner band at the IgX primer.  Results for both σ positive and negative sorted 
cells as well as all negative controls for positive and negative cells were negative as 
expected (Figure 21).   
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In the second PCR, the Igσ positive and negative sorted cells resulted in positive 
bands.  Although, primers were made to be 200 bps, the bands for IgY varied slightly 
from Igλ.   Also, Igσ negatively sorted cells had another positive band at approximately 
850 bp.   Igλ positive and negatively sorted cells with IgY and Igλ primer were not as 
robust as expected for positively sorted IgY cell. However, Igκ sorted cells had 
anticipated bands for IgY and Igλ (Figure 22).  
Figure 21: cDNA (σ & к) with IgM, IgX, Igκ and Igσ Primers. 
The (-) Are Negatively Sorted Cells and (+) Are Positively 
Sorted Cells.   
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    Figure 22: cDNA (σ, λ & к) with IgY & Igλ Primers. The 
(-) Are Negatively Sorted Cells and (+) Are Positively 
Sorted Cells. 
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4. DISCUSSION 
 
 
 
4.1 Development of Frog Experimental Techniques 
The ideal concentration for sedation of frogs weighing 20-40 g for 
immunizations was determined at 2 g/L of MS-222 for 15 minutes. This concentration 
provided the quickest time to sedate the frogs with the widest safety margin against 
overdose.  At this concentration and duration of immersion, there were no complications 
in handling the animal, inserting the microchip identification, guiding the gavage needle 
and delivering the oral innoculant.  Euthanasia was determined to be less than 15 
minutes based on 5 g/L concentration.  Death was always confirmed by a secondary 
method of euthanasia such as pithing, exsanguination or decapitation.  Incision of the 
base of the heart, provided the most consistent and reliable method of terminal blood 
collection in 20-40 g Xenopus frogs.    
 
4.2 Gavage Technique 
Using a straight 20 gauge 1.5 inch stainless feeding needle provided the best 
delivery method for gavage of 20-40 g Xenopus.  Frogs sedated at 2 g/L for 15 minutes 
were easier to orally immunize than frogs sedated for only 10 minutes at the same 
concentration.  As a method of avoiding noxious stimuli, frogs can quickly expel the 
contents of their stomach. It is also a common sign of illness in amphibians, especially 
frogs and toads.  Animals sedated in both concentrations recovered without 
complications or regurgitation of stomach contents.  Problems reported in small animals 
53 
 
 
53 
include perforation of the esophagus, gavage into the trachea or lungs or even death.  
There were no adverse effects observed from the gavage method seen in Xenopus, 
although problems reported in small animals include perforation of the esophagus, 
gavage into the trachea or lungs.  Sequelae of these events include sepsis or even death 
(Atcha et al. 2010) .    
 
4.3 Immunizations 
For the immunization protocol, the increase in sedation time, decrease 
concentration of innoculant and larger frog all helped in oral immunization delivery by 
preventing innoculants from leaking out of the mouth.  Although, this was a novel 
procedure, sham immunizations before the initial experimental group would have been 
ideal to determine the best variables for antigen delivery.  Control immunizations should 
have been immunized with inert substance such as sterile saline instead of receiving no 
treatment.  Using the baseline serum as control would have helped make observations as 
to whether immunizations were eliciting significant immune response.  Also, 
withholding food may have helped empty the stomach and prepare for antigen 
acceptance.  
 
4.4 ELISA 
Using the first total ELISA protocol, a higher but not significant serum IgM level 
was detected between the orally immunized frogs and the intraperitoneally immunized 
frogs.  However, total IgX levels were higher in orally immunized frogs compared to 
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systemically immunized animals and non-immunized controls.  The result of the first 
trial of oral immunization delivery supports my hypothesis that IgX, a proposed analog 
of IgA, would be specifically produced with oral immunization compared to systemic 
immunization.  Again this is the first evidence that oral immunization elicits an IgX 
response.   
In the second, antigen-specific ELISA protocol, results showed significant serum 
IgM response between intraperitoneally immunized frogs compared to orally and non-
immunized animals.   This contrasts with serum IgX antigen-specific ELISA protocol in 
which no significant difference was measured between any of the three immunizations.   
Incubating the tablet in DMSO at 37ºC provided rapid and accurate results and 
proper substrate solution to use for ELISA.  Other variables that would have decreased 
variance or increased sensitivity of ELISA results are pre-bleeding of frogs to use as 
controls instead of using non-immunized control frogs.  The baseline serum of each frog 
would have served as an internal control for each PO or IP immunization.  
Unfortunately, the amount of serum collected via survival method in a 20-40 g frog 
(100-150 μl) would have been a limiting factor for this method, although this method has 
been subsequently developed in the lab (publication pending).  Also, repeating each frog 
immunization ELISA in triplicate would have given an average response and eliminated 
any outliers caused by inconsistencies in ELISA procedures.   
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4.5 Phylogenetic Analysis 
Recent data now allow more rigorous studies of the natural history of tetrapod 
genes, and more immunogenetic studies and genome projects will only help further 
define immunoglobulin evolution. Sequence similarities along with structural 
resemblance to IgM, suggest that IgX might be thefunctional analog, not the ortholog of 
IgA. The IgA of Aves appears to be a mucosal functional analog of mammalian IgA 
(Mansikka 1992) and there is high sequence identity suggesting orthology (Choi et al. 
2010b), although there are four C domains in avian IgA suggesting a deletion occurred 
to yield the mammalian IgA of three (Aveskogh and Hellman 1998).   
Immunoglobulin heavy constant regions were analyzed.  Alignments were 
initially made in Bioedit with ClustalW and MEGA was used to infer the phylogenetic 
relationships of immunoglobulin C regions. Trees were drawn employing pairwise 
deletion of gaps and the Dayhoff rate matrix. Neighbor-joining consensus trees were 
made from 1000 bootstrap replicates and for the first time, results showed IgX and IgA 
were closely related.   
In addition to phylogenies using the entire C region, the relationships of these 
isotypes are being studied with phylogenies of individual C domains.  The tree of the 
individual domains used in the previous C region tree show in (Figure 23), uses different 
colors to show isotype and shapes to show domains. 
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Figure 23: Individual Constant Region Tree. 
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A rectangular representation of the area in the red box is depicted in Figure 24.  
The third constant domain of IgX groups with not only IgA C3 but also IgA C2 of 
mammals, suggesting exon duplication or homogenization. Therefore, the C2 domain of 
mammalian IgA may not come from the same ancestor of C2 of amphibian IgX or C2 
reptilian IgA, but rather a more recent duplication within the mammalian IgA loci. Thus 
the actual history of the genes that encode the isotypes may be too complex to explain as 
descent of the entire C region en block.  
 
Figure 24: Closer Look at Individual Constant Region Tree. 
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4.6 Ig Heavy/Ig Light Isotype Relationships 
 In mammals, Igκ and Igλ light chain can be found on any of the five major 
classes of immunoglobulin heavy chain.  In lower vertebrates some heavy/light chain 
isotype preference has been shown at the protein level (Miracle et al. 2001). In Xenopus 
previous literature has shown that an isotype found in cold- blooded vertebrates, Igσ has 
a preference for the two T cell independent IgH isotypes found in gut: IgM and IgX, but 
not IgY (Hsu et al. 1991) (Criscitiello and Flajnik 2007).  Although, these isotypes have 
been identified, there is still little evidence to indicate their distinct functional roles.   
To follow up on this protein observation, we wanted to sort B lymphocytes based 
on light chain and quantify heavy chain expression by PCR.  The first objective was to 
sort labeled B cells from the spleen and the second to determine immunoglobulin heavy 
chain to immunoglobulin light chain association.  Cell sorting by the MACS system 
averaged 50,000 positively labeled cells per sort and 2.0 X 106 unlabeled cells as control.  
In the first PCR attempt, only Igκ and Igσ positive and negative cells were tested against 
IgM, IgX and Igκ primers.  Unfortunately, the Igλ positive and negatively sorted cells 
with IgY primer were not as robust as expected for positively sorted IgY cells in the 
second PCR.  This was perhaps due to poor cell sorting technique.  Our results show that 
for positively and negatively sorted Igσ and Igκ cells in the first PCR and Igσ, Igλ and 
Igκ in the second PCR positive bands as expected.  This is because only one cell can 
cause a band.  For this reason, real time PCR is a more sensitive and specific test to 
quantify a positive response.    
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5. CONCLUSION 
 
I proposed that IgX, a functional analog of our IgA, will increase with oral 
inoculation compared to intraperitoneal injection and that IgM will be increased in 
systemically immunized animals compared to orally challenged animals.  My results 
support an increase in serum IgM from systemic immunization compared with serum 
IgM levels from oral immunization.  Although this hypothesis was stated in by Hsu (Hsu 
1998), this is the first experiment that compared orally immunized animals with 
systemically immunized animals.   
Improvements for future studies include sham immunizations before the initial 
experimental group.  This would have been ideal to determine the best variables for 
antigen delivery.  Control animals should have been immunized with inert substance 
such as sterile saline instead of receiving no treatment. Other improvements include 
taking baseline serum (or prebleed) for each frog to use as control.  Also, withholding 
food may have helped empty the stomach and prepare for antigen acceptance.  As the 
studies continue, the use of larger immunization sets will provide statistical significance.  
Future research also, includes refining the immunization and both total and antigen-
specific ELISA protocols. Ideally, the IgX antibodies in the gut mucosal epithelium 
should be compared to serum IgM in systemically immunized frogs.  This protocol is 
currently being refined.  Ongoing studies will focus on determining if oral immunization 
of the frog gut epithelium will elicit a specific B cell immune response without T helper 
cell activation.  This is currently being performed by Sara Mashoof in Dr. Criscitiello’s 
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lab.  Around day 10 of larval development, we can ablate the thymus with cauterization 
under the dissecting microscope (Figure 25).  At this stage common lymphoid 
progenitors have not seeded the thymus and the post metamorphosis frog immune 
system can be studied, never having had T cells. 
T cell deficiency results from thymectomy of larval Xenopus before stem cell 
migration to the developing thymus occurs (Horton et al. 1998).  These animals have 
decreased anti-tumor response (Robert et al. 1997) and decrease allograft immunity 
(Horton et al. 1998).  Thymectomized frogs have no peripheral T cells but B cells and 
NK cell numbers are increased (Horton et al. 2000).  However, thymectomized adult 
frogs express IgM and IgX, but not IgY in sera (Hsu 1998). 
 
 
 
 
 
 
Figure 25: Larval Thymectomy.  The Red Box in the Photo on the Left Shows 
the Thymus Before Cauterization.  The Photo on the Right Shows After 
Cauterization.   
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In summary, oral and systemic immunizations were refined in the amphibian 
model, the most primitive animal to share our Ig heavy chain switch mechanism.  
Methods of sedation, oral gavage, immunization and ELISA were techniques developed 
for this study.  Results of ELISA show a promising significant IgX response to oral 
immunization, but not a significant IgM response to systemic immunization.  The entire 
C domain phylogeny reveal an intimate relationship between amphibian IgX, avian IgA 
and mammalian IgA, supporting the theory that IgX gave rise to IgA.  Real time PCR 
will study light chain association in the cells that were sorted by MACS.  Ongoing 
studies will continue to resolve functional and evolutionary roles of the heavy and light 
chain isotype of the first vertebrate to use class switch.  Larval thymectomized Xenopus 
are currently being immunized orally and systemically.  
Whereas we used to think IgX was a mucosal innovation of only amphibian 
lineage descendent of IgM, we now have evidence that it in fact gave rise to our IgA and 
perhaps one day the nomenclature will be condensed (Figure 26).  It is satisfying that the 
organization of the known tetrapod Ig heavy loci do not complicate this hypothesis as 
loci encoding IgA and IgX share similar syntenic relationship from frog to man (Figure 
27).  To support this idea further, we only need to look at the five isotypes we commonly 
study.  They may be derived from two sources; the very genesis of our adaptive system 
in the cartilaginous fish (IgM and IgD), and then a radiation after the innovation of class 
switch in amphibians, with IgX going on to our IgA  and IgY spawning IgG and IgE 
(Figure 28).   
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Figure 26: Natural History of Our Antibody Isotypes. 
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Figure 27: Syntenic Relationships Between IgH. These Heavy Chain Loci Depict the 
Arrangement of Constant Region Encoding Exon Clusters of Common Tetrapods. 
 
 
 
64 Figure 28: Proposed Origin of IgG and IgE and IgA.   
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